Comprehensive semen examination in patients with pancreatic-sufficient and pancreatic-insufficient cystic fibrosis

We examined a cohort of 93 cystic fibrosis (CF) male patients who were pancreatic-sufficient (PS-CF; n=40) or pancreatic-insufficient (PI-CF; n = 53). Complex semen examination was performed, including standard semen analysis, quantitative karyological analysis (QKA) of immature germ cells (IGCs), transmission electronic microscopy (TEM), biochemical analysis, and sperm DNA fragmentation by terminal deoxynucleotidyl transferase-mediated dUTP nickend labeling (TUNEL) assay. Azoospermia was diagnosed in 83 (89.2%) patients. The other 10 (10.8%) patients were found to be nonazoospermic and showed various spermatological diagnoses (asthenozoospermia, n = 2; asthenoteratozoospermia, n = 3; oligoasthenozoospermia, n = 1; oligoasthenoteratozoospermia, n = 3; and normozoospermia, n = 1) with no specific morphological abnormalities. Oligospermia was detected in 89.2% azoospermic and 30.0% nonazoospermic patients. Low seminal pH (<7.0) was found in 74 (89.2%) of 83 azoospermic patients. Moderate leukocytospermia (2.0 × 10[6]–2.2 × 10[6] ml−1) was revealed in 2.4% azoospermic and 40.0% nonazoospermic semen samples. The signs of partial meiotic arrest at prophase I were found in 4 of 6 nonazoospermic patients examined by QKA of IGCs. The content of fructose and citrate was low in oligospermic and normal in nonoligospermic semen samples. An increased percentage (>30%) of spermatozoa with noncondensed (“immature”) chromatin was revealed in 2 of 6 nonazoospermic semen samples analyzed by TEM.

[1]  A. Agarwal,et al.  TUNEL assay—Standardized method for testing sperm DNA fragmentation , 2020, Andrologia.

[2]  M. Moghadasian,et al.  Dietary fatty acids affect semen quality: a review , 2015, Andrology.

[3]  T. Freour,et al.  [Congenital bilateral absence of vas deferens: From diagnosis to assisted reproductive techniques - the experience of three centers]. , 2015, Gynecologie, obstetrique & fertilite.

[4]  George P Patrinos,et al.  Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene , 2013, Nature Genetics.

[5]  Wen Ying Chen,et al.  Defective CFTR-Dependent CREB Activation Results in Impaired Spermatogenesis and Azoospermia , 2011, PloS one.

[6]  T. Worgall.  Lipid metabolism in cystic fibrosis , 2009, Current opinion in clinical nutrition and metabolic care.

[7]  Wen Ying Chen,et al.  Cystic fibrosis transmembrane conductance regulator is vital to sperm fertilizing capacity and male fertility , 2007, Proceedings of the National Academy of Sciences.

[8]  C. Clavel,et al.  Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France , 2000, Human mutation.

[9]  M. Loriot,et al.  Histological and genetic analysis and risk assessment for chromosomal aberration after ICSI for patients presenting with CBAVD. , 2000, Human reproduction.

[10]  C. Férec,et al.  Mutations in the cystic fibrosis gene in men with congenital bilateral absence of the vas deferens. , 1996, Molecular human reproduction.

[11]  M. Corey,et al.  Diversity of reproductive tract abnormalities in men with cystic fibrosis. , 1996, JAMA.

[12]  M. Buchwald,et al.  Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. , 1994, The American journal of pathology.

[13]  S. Gould,et al.  Expression of the cystic fibrosis gene in human foetal tissues. , 1993, Human molecular genetics.

[14]  M. Griswold,et al.  CFTR expression is regulated during both the cycle of the seminiferous epithelium and the oestrous cycle of rodents , 1993, Nature Genetics.

[15]  M. White,et al.  Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. , 1992 .

[16]  B. Strandvik,et al.  The fertility potential of male cystic fibrosis patients. , 1991, International journal of andrology.

[17]  J. Lavinha,et al.  A fertile male with cystic fibrosis: molecular genetic analysis. , 1991, Journal of medical genetics.

[18]  E. Nieschlag,et al.  The influence of inflammation of the human male genital tract on secretion of the seminal markers alpha-glucosidase, glycerophosphocholine, carnitine, fructose and citric acid. , 1990, International journal of andrology.

[19]  Philippe Roussel,et al.  Abnormal distribution of CF ΔF508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens , 1990, The Lancet.

[20]  T. Boat,et al.  OBSTRUCTIVE AZOOSPERMIA AS A DIAGNOSTIC CRITERION FOR THE CYSTIC FIBROSIS SYNDROME , 1982, The Lancet.

[21]  B. Lunenfeld,et al.  Morphological characterization of abnormal human spermatozoa using transmission electron microscopy. , 1980, Archives of andrology.

[22]  J. Kattwinkel,et al.  Fertility in males with cystic fibrosis. , 1972, Lancet.

[23]  H. Shwachman,et al.  Increased incidence of inguinal hernia, hydrocele, and undescended testicle in males with cystic fibrosis. , 1971, Pediatrics.

[24]  H. Shwachman,et al.  Reproductive failure in males with cystic fibrosis. , 1968, The New England journal of medicine.

[25]  C. Castellani,et al.  Cystic fibrosis: a clinical view , 2016, Cellular and Molecular Life Sciences.

[26]  Jianmin Yu,et al.  CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. , 2012, Human reproduction.

[27]  Organización Mundial de la Salud.  WHO laboratory manual for the examination and processing of human semen , 2010 .

[28]  M. Claustres.  Molecular pathology of the CFTR locus in male infertility. , 2005, Reproductive biomedicine online.

[29]  A. Wetzels,et al.  Chromatin condensation and DNA damage of human epididymal spermatozoa in obstructive azoospermia. , 2004, Reproductive biomedicine online.

[30]  J. Riordan.  Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA , 1989 .